Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

A Protocol to Assess Feasibility, Acceptability, and Usability of Mobile Technology for Symptom Management in Pediatric Transplant Patients

Vaughn, Jacqueline; Summers-Goeckerman, Erika; Shaw, Ryan J.; Shah, Nirmish

doi: 10.1097/NNR.0000000000000343
BRIEF REPORTS
Buy

Background Pediatric blood and marrow transplant (PBMT) patients experience significant symptom distress, and the use of mobile health (mHealth) technologies may enhance symptom management by providing patient-generated health data to foster personalized health strategies.

Objectives The aim of this study was to present a study protocol to explore feasibility, acceptability, and usability of integrating mHealth technologies to collect and monitor symptom data for PBMT patients.

Methods An exploratory mixed-methods design is employed for 20 PBMT patients to monitor symptoms using real-time data from two mHealth devices: (a) a self-developed mHealth application and (b) a wearable tracking device. Patient-Reported Outcomes Measurement Information System surveys for fatigue, pain, and sleep disturbance are obtained monthly. Interviews are conducted to obtain further feasibility and usability data.

Results The study began in October 2017; data collection should be completed in 2018. Feasibility and usability results to monitor and record symptom-related data daily via mobile devices will be reported. Patient-Reported Outcomes Measurement Information System surveys and interviews will further explore patients’ symptoms and experiences with the mobile devices.

Discussion This study will be among the first to explore the feasibility, acceptability, and usability of integrating multiple mHealth technologies to obtain patient-generated symptom data for the PBMT population. Results will enhance our understanding of how these data present, interact, and cluster together throughout the posttransplant period for these children and lead to symptom management strategies. Results will focus on a high-risk population that potentially stands to benefit from the use of mobile technologies.

Jacqueline Vaughn, BSN, RN, CHSE, is a PhD candidate, Duke University School of Nursing, Durham, North Carolina.

Ryan J. Shaw, PhD, RN, is Associate Professor, Duke University School of Nursing, Durham, North Carolina.

Erika Summers-Goeckerman, MSN, RN, CPNP-AC, is Pediatric Blood and Marrow Transplant Nurse Practitioner, Hematology-Oncology Division, Duke Health, Durham, North Carolina.

Nirmish Shah, MD, is Assistant Professor of Medicine, Hematology-Oncology Division, Duke Health, Durham, North Carolina.

Accepted for publication October 14, 2018.

The research reported in this publication is supported in part by the National Institute of Nursing Research of the National Institutes of Health under Award F31NR018100. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional funding is supported by a Duke Pediatric Chairs Award 2016. This work is dedicated to Dr. Cheryl Rodgers, PhD, RN, CPNP, CPON.

The authors have no conflicts of interest to report.

Corresponding author: Jacqueline Vaughn, BSN, RN, CHSE, Duke University School of Nursing, 307 Trent Drive, Durham, NC 27710 (e-mail: jacqueline.vaughn@duke.edu).

Ethical Conduct of Research: The medical center institutional review board approved the study protocol (Pro00068979). All authors complied with our institution’s ethical standards.

Clinical Trial Registration: Trial Number: NCT02895841. The trial was registered September 12, 2016; the first patient enrolled for this substudy was October 25, 2017. Link: https://clinicaltrials.gov/ct2/show/NCT02895841

Online date: February 1, 2019

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved